International audiencePosterior reversible encephalopathy syndrome is a well-known complication of treatment by tacrolimus. We report 2 cases of lung transplant recipients treated with tacrolimus who developed cerebral microbleeds on T2∗-weighted sequences in the acute setting of posterior reversible encephalopathy syndrome. Cerebral microbleeds may be a marker of tacrolimus-induced vasculopathy that may be detected earlier by neuropsychological and magnetic resonance imaging monitoring in transplant recipients treated with tacrolimus
Item does not contain fulltextA 24 year old woman presented with a sudden excruciating headache mimi...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Previously described neurologic damage induced by immunosuppressive treatments includes transient or...
International audiencePosterior reversible encephalopathy syndrome is a well-known complication of t...
Posterior reversible encephalopathy syndrome is a well-known complication of treatment by tacrolimus...
Copyright © 2013 L. Mechtouff et al. This is an open access article distributed under the Creative C...
Background. Tacrolimus-associated encephalopathy (TAC-E) is usually described under the term of post...
Since solid organ and hematopoietic stem cell transplantations have been performed increasingly rece...
WOS: 000283567300011PubMed ID: 20933182Posterior reversible encephalopathy syndrome, a serious neuro...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant rejection in i...
Posterior reversible encephalopathy syndrome is a neurological problem characterized by headache, al...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Introduction: Posterior reversible encephalopathy syndrome is a rare neurologic complication that ca...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
Item does not contain fulltextA 24 year old woman presented with a sudden excruciating headache mimi...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Previously described neurologic damage induced by immunosuppressive treatments includes transient or...
International audiencePosterior reversible encephalopathy syndrome is a well-known complication of t...
Posterior reversible encephalopathy syndrome is a well-known complication of treatment by tacrolimus...
Copyright © 2013 L. Mechtouff et al. This is an open access article distributed under the Creative C...
Background. Tacrolimus-associated encephalopathy (TAC-E) is usually described under the term of post...
Since solid organ and hematopoietic stem cell transplantations have been performed increasingly rece...
WOS: 000283567300011PubMed ID: 20933182Posterior reversible encephalopathy syndrome, a serious neuro...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant rejection in i...
Posterior reversible encephalopathy syndrome is a neurological problem characterized by headache, al...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Introduction: Posterior reversible encephalopathy syndrome is a rare neurologic complication that ca...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
Item does not contain fulltextA 24 year old woman presented with a sudden excruciating headache mimi...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Previously described neurologic damage induced by immunosuppressive treatments includes transient or...